| PRD_000009 | Name: | Actinomycin Z3 | Formula: | C62 H83 Cl N12 O18 | Description: | ACTINOMYCIN Z3 CONSISTS OF TWO PENTAMER
RINGS LINKED BY THE CHROMOPHORE (PXZ) | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
| PRD_000010 | Name: | 7-AminoActinomycin | Formula: | C62 H87 N13 O16 | Description: | ACTINOMYCIN D CONSISTS OF TWO PENTAMER
RINGS LINKED BY THE CHROMOPHORE (PX1)
THE CHROMOPHORE PX1 IS A MODIFIED PXZ
WITH C-NH2 REPLACING C-H IN POSITION 7 OF THE
PHENOXAZONE RING. | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
| PRD_000011 | Name: | N8-Actinomycin D | Formula: | C61 H85 N13 O16 | Description: | ACTINOMYCIN D CONSISTS OF TWO PENTAMER
RINGS LINKED BY THE CHROMOPHORE (PXA)
THE CHROMOPHORE PXA IS A MODIFIED PXZ WITH
N REPLACING C-H IN POSITION 8 OF THE
PHENOXAZONE RING. | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
| PRD_000900 | Name: | N-(benzylsulfonyl)-D-leucyl-N-(4-carbamimidoylbenzyl)-L-prolinamide | Formula: | C26 H35 N5 O4 S | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
| PRD_000020 | Name: | D-phenylalanyl-N-[(2S,3S)-6-{[amino(iminio)methyl]amino}-1-chloro-2-hydroxyhexan-3-yl]-L-prolinamide | Formula: | C21 H34 Cl N6 O3 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000021 | Name: | D-phenylalanyl-N-[(3S)-6-carbamimidamido-1-chloro-2-oxohexan-3-yl]-L-prolinamide | Formula: | C21 H31 Cl N6 O3 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000102 | Name: | CYCLIC HEXAPEPTIDE RR(NAL)(NAL)RF | Formula: | C53 H70 N15 O6 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000103 | Name: | CYCLIC HEXAPEPTIDE KKWWKF | Formula: | C49 H68 N11 O6 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000104 | Name: | CYCLIC HEXAPEPTIDE RRYYRF | Formula: | C45 H66 N15 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000910 | Name: | B4Z inhibitor | Formula: | C24 H44 N6 O6 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
| PRD_000105 | Name: | CYCLIC HEXAPEPTIDE CYC-(RRWWRF) | Formula: | C49 H68 N17 O6 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000911 | Name: | C4Z inhibitor | Formula: | C27 H42 N6 O6 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
| PRD_000106 | Name: | BOC-(D-NLE-L-NLE)4-D-NLE(METHYL)-L-NLE-D-NLE-L-NLE METHYL ESTER | Formula: | C79 H146 N12 O15 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000912 | Name: | C6Z inhibitor | Formula: | C34 H54 N8 O10 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
| PRD_000107 | Name: | H-(L-TYR-D-TYR)4-LYS-OH | Formula: | C78 H87 N10 O18 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000913 | Name: | M4Z inhibitor | Formula: | C24 H39 N7 O6 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
| PRD_000108 | Name: | HCO-(D-NLE-L-NLE)3-D-MENLE-L-NLE-D-NLE-L-NLE-OME | Formula: | C63 H116 N10 O12 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000109 | Name: | BOC-L-NLE-(D-NLE-L-NLE)5-D-NLE(METHYL)-L-NLE-D-NLE-L-NLE METHYL ESTER | Formula: | C96 H177 N15 O18 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000919 | Name: | N-{(2R)-2-[2-(hydroxyamino)-2-oxoethyl]-4-methylpentanoyl}-3-methyl-L-valyl-N-(2-aminoethyl)-L-alaninamide | Formula: | C19 H37 N5 O5 | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
| PRD_000110 | Name: | DLY-HGL-AGD-LHC-AGD-LHC-CUD-LYS | Formula: | C60 H81 N34 O15 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000920 | Name: | SAMAROSPORIN I | Formula: | C77 H120 N16 O19 | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
| PRD_000117 | Name: | ARYLOMYCIN A2 | Formula: | C42 H60 N6 O11 | Description: | ARYLOMYCIN A2 IS A BIARYL-BRIDGED LIPOPEPTIDE. THE SCAFFOLD IS MADE OF TWO PARTS: (1) N-TERM EXOCYCLIC TRIPEPTIDE (2)
A TRICYCLIC PEPTIDE, WITH [3,3] BIARYL BOND BETWEEN RESIDUE 4 AND 6 AN ISO-C12 FATTY ACID IS LINKED TO RESIDUE 1. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000921 | Name: | Noxa BH3 peptide (cysteine-mediated cross-linked) | Formula: | C106 H179 N33 O25 S2 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
| PRD_000142 | Name: | Cyclosporin A | Formula: | C62 H111 N11 O12 | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000143 | Name: | Cyclosporin D | Formula: | C64 H115 N11 O12 S | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI.
CYCLOSPORIN D IS A NATURAL ANALOG OF CYCLOSPORIN A,
OBTAINED FROM A DIFFERENT NUTRIENT BROTH AND
DIFFERS FROM CYCLOSPORIN IN RESIDUE 6 (ABA6VAL). | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|